ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
Europe - FRA:ACT - DE000A2YNT30 - Common Stock
138.9 EUR
-4.5 (-3.14%)
Taking everything into account, ACT scores 7 out of 10 in our fundamental rating. ACT was compared to 67 industry peers in the Chemicals industry. ACT gets an excellent profitability rating and is at the same time showing great financial health properties. ACT is not valued too expensively and it also shows a decent growth rate. These ratings could make ACT a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
ACT had positive earnings in the past year.
ACT had a positive operating cash flow in the past year.
Each year in the past 5 years ACT has been profitable.
ACT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of ACT (10.48%) is better than 95.52% of its industry peers.
The Return On Equity of ACT (26.66%) is better than 98.51% of its industry peers.
ACT has a better Return On Invested Capital (13.72%) than 95.52% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACT is significantly above the industry average of 7.01%.
The 3 year average ROIC (12.06%) for ACT is below the current ROIC(13.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.48% | ||
| ROE | 26.66% | ||
| ROIC | 13.72% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
ACT has a better Profit Margin (10.43%) than 83.58% of its industry peers.
In the last couple of years the Profit Margin of ACT has grown nicely.
The Operating Margin of ACT (15.34%) is better than 86.57% of its industry peers.
ACT's Operating Margin has improved in the last couple of years.
ACT's Gross Margin of 65.74% is amongst the best of the industry. ACT outperforms 97.01% of its industry peers.
ACT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.34% | ||
| PM (TTM) | 10.43% | ||
| GM | 65.74% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ACT is creating value.
ACT has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACT has less shares outstanding
ACT has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.82 indicates that ACT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.82, ACT belongs to the top of the industry, outperforming 89.55% of the companies in the same industry.
The Debt to FCF ratio of ACT is 1.15, which is an excellent value as it means it would take ACT, only 1.15 years of fcf income to pay off all of its debts.
ACT has a Debt to FCF ratio of 1.15. This is amongst the best in the industry. ACT outperforms 97.01% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that ACT is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.18, ACT is doing good in the industry, outperforming 70.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 1.15 | ||
| Altman-Z | 4.82 |
ROIC/WACC1.91
WACC7.17%
2.3 Liquidity
A Current Ratio of 2.84 indicates that ACT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.84, ACT belongs to the top of the industry, outperforming 82.09% of the companies in the same industry.
ACT has a Quick Ratio of 1.73. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
ACT's Quick ratio of 1.73 is fine compared to the rest of the industry. ACT outperforms 77.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.73 |
3. Growth
3.1 Past
ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.65%, which is quite impressive.
The Earnings Per Share has been growing by 24.60% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 1.03% in the past year.
ACT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.06% yearly.
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%
3.2 Future
ACT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.26% yearly.
The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y18.28%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
EPS Next 5Y20.26%
Revenue Next Year2.83%
Revenue Next 2Y5.94%
Revenue Next 3Y8.48%
Revenue Next 5Y6.02%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 24.33 indicates a rather expensive valuation of ACT.
ACT's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of ACT to the average of the S&P500 Index (26.28), we can say ACT is valued inline with the index average.
With a Price/Forward Earnings ratio of 19.91, ACT is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACT is on the same level as its industry peers.
ACT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 33.61, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.33 | ||
| Fwd PE | 19.91 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ACT.
64.18% of the companies in the same industry are more expensive than ACT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.19 | ||
| EV/EBITDA | 12.94 |
4.3 Compensation for Growth
ACT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of ACT may justify a higher PE ratio.
A more expensive valuation may be justified as ACT's earnings are expected to grow with 19.49% in the coming years.
PEG (NY)1.33
PEG (5Y)0.99
EPS Next 2Y17.04%
EPS Next 3Y19.49%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.27%, ACT has a reasonable but not impressive dividend return.
ACT's Dividend Yield is slightly below the industry average, which is at 3.26.
With a Dividend Yield of 1.27, ACT pays less dividend than the S&P500 average, which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.27% |
5.2 History
The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
31.40% of the earnings are spent on dividend by ACT. This is a low number and sustainable payout ratio.
The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP31.4%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
FRA:ACT (11/11/2025, 1:40:33 PM)
138.9
-4.5 (-3.14%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners35.95%
Inst Owner ChangeN/A
Ins Owners30.48%
Ins Owner ChangeN/A
Market Cap1.41B
Revenue(TTM)555.53M
Net Income(TTM)57.92M
Analysts81.82
Price Target161.52 (16.29%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.27% |
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP31.4%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)33.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.7%
EPS NY rev (3m)3.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.33 | ||
| Fwd PE | 19.91 | ||
| P/S | 2.55 | ||
| P/FCF | 34.19 | ||
| P/OCF | 12.56 | ||
| P/B | 6.51 | ||
| P/tB | 6.62 | ||
| EV/EBITDA | 12.94 |
EPS(TTM)5.71
EY4.11%
EPS(NY)6.98
Fwd EY5.02%
FCF(TTM)4.06
FCFY2.93%
OCF(TTM)11.06
OCFY7.96%
SpS54.57
BVpS21.35
TBVpS20.99
PEG (NY)1.33
PEG (5Y)0.99
Graham Number52.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.48% | ||
| ROE | 26.66% | ||
| ROCE | 19.03% | ||
| ROIC | 13.72% | ||
| ROICexc | 16.02% | ||
| ROICexgc | 16.17% | ||
| OM | 15.34% | ||
| PM (TTM) | 10.43% | ||
| GM | 65.74% | ||
| FCFM | 7.45% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexgc growth 3Y25.57%
ROICexgc growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score7
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 1.15 | ||
| Debt/EBITDA | 0.36 | ||
| Cap/Depr | 270.53% | ||
| Cap/Sales | 12.82% | ||
| Interest Coverage | 42.05 | ||
| Cash Conversion | 100.91% | ||
| Profit Quality | 71.41% | ||
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.73 | ||
| Altman-Z | 4.82 |
F-Score7
WACC7.17%
ROIC/WACC1.91
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
EPS Next Y18.28%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
EPS Next 5Y20.26%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%
Revenue Next Year2.83%
Revenue Next 2Y5.94%
Revenue Next 3Y8.48%
Revenue Next 5Y6.02%
EBIT growth 1Y19.3%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year49.4%
EBIT Next 3Y27.83%
EBIT Next 5Y19.11%
FCF growth 1Y37.04%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y113.41%
OCF growth 3Y34.7%
OCF growth 5Y19.23%
ALZCHEM GROUP AG / ACT.DE FAQ
Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.
What is the valuation status of ALZCHEM GROUP AG (ACT.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for ALZCHEM GROUP AG?
ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.
What are the PE and PB ratios of ALZCHEM GROUP AG (ACT.DE) stock?
The Price/Earnings (PE) ratio for ALZCHEM GROUP AG (ACT.DE) is 24.33 and the Price/Book (PB) ratio is 6.51.
What is the financial health of ALZCHEM GROUP AG (ACT.DE) stock?
The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.